BIOCERES CROP SOLUTIONS CORP. Additions Other Than Through Business Combinations Biological Assets
BIOCERES CROP SOLUTIONS CORP. (BIOX) reported Additions Other Than Through Business Combinations Biological Assets of $1.04 million for the 3-month period ending 2025-09-30, per its 6-K filed 2025-11-26.
Financial Statements › Notes
ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets · last filed 2025-11-26
- BIOCERES CROP SOLUTIONS CORP. additions other than through business combinations biological assets for the quarter ending 2025-09-30 was $1.04M.
- BIOCERES CROP SOLUTIONS CORP. additions other than through business combinations biological assets for the quarter ending 2024-06-30 was $343.88K, a 134.11% increase year-over-year.
- BIOCERES CROP SOLUTIONS CORP. additions other than through business combinations biological assets for the quarter ending 2024-03-31 was $1.37M, a 12.82% increase year-over-year.
- BIOCERES CROP SOLUTIONS CORP. additions other than through business combinations biological assets for the quarter ending 2023-12-31 was $355.01K, a 40.35% decline year-over-year.
| Period end | Additions Other Than Through Business Combinations Biological Assets 3 month | Additions Other Than Through Business Combinations Biological Assets 6 month | Additions Other Than Through Business Combinations Biological Assets 9 month | Additions Other Than Through Business Combinations Biological Assets 12 month |
|---|---|---|---|---|
| 2025-09-30 | $1.04M 6-K · filed 2025-11-26 | |||
| 2025-06-30 | $4.44M 6-K · filed 2025-11-26 | |||
| 2024-06-30 | $343.88K derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10 | $1.71M derived: sum of 2 quarters · filed 2025-11-10 | $2.06M derived: sum of 3 quarters · filed 2025-11-10 | $2.65M 20-F · filed 2025-11-10 |
| 2024-03-31 | $1.37M derived: 6-K 9 month − 6-K 6 month · filed 2024-05-29 | $1.72M derived: sum of 2 quarters · filed 2024-05-29 | $2.30M 6-K · filed 2024-05-29 | $2.45M derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-12-31 | $355.01K derived: 6-K 6 month − 6-K 3 month · filed 2024-02-28 | $938.37K 6-K · filed 2024-02-28 | $1.09M derived: sum of 3 quarters · filed 2024-10-30 | $2.30M derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-09-30 | $583.36K 6-K · filed 2023-11-29 | $730.25K derived: sum of 2 quarters · filed 2024-10-30 | $1.94M derived: sum of 3 quarters · filed 2024-10-30 | $2.54M derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-06-30 | $146.89K derived: 20-F 12 month − 6-K 9 month · filed 2024-10-30 | $1.36M derived: sum of 2 quarters · filed 2024-10-30 | $1.95M derived: sum of 3 quarters · filed 2024-10-30 | $2.45M 20-F · filed 2024-10-30 |
| 2023-03-31 | $1.21M derived: 6-K 9 month − 6-K 6 month · filed 2024-05-29 | $1.81M derived: sum of 2 quarters · filed 2024-05-29 | $2.31M 6-K · filed 2024-05-29 | -$9.93M derived: sum of 4 quarters · filed 2024-05-29 |
| 2022-12-31 | $595.21K derived: 6-K 6 month − 6-K 3 month · filed 2024-02-28 | $1.10M 6-K · filed 2024-02-28 | -$11.14M derived: sum of 3 quarters · filed 2024-02-28 | -$2.06M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-09-30 | $501.47K 6-K · filed 2023-11-29 | -$11.73M derived: sum of 2 quarters · filed 2023-11-29 | -$2.65M derived: sum of 3 quarters · filed 2023-11-29 | |
| 2022-06-30 | -$12.24M derived: 20-F 12 month − 6-K 9 month · filed 2023-11-14 | -$3.15M derived: sum of 2 quarters · filed 2023-11-14 | $32.38M 20-F · filed 2023-11-14 | |
| 2022-03-31 | $9.08M derived: 6-K 9 month − 6-K 6 month · filed 2023-05-24 | $44.62M 6-K · filed 2023-05-24 | ||
| 2021-12-31 | $35.54M 6-K · filed 2023-02-28 | |||
| 2021-06-30 | $25.72M 20-F · filed 2023-11-14 | |||
| 2020-12-31 | $16.04M 6-K · filed 2022-02-25 | |||
| 2020-06-30 | $1.23M 20-F · filed 2022-10-28 | |||
| 2019-12-31 | $689.31K 6-K · filed 2021-02-26 | |||
| 2019-06-30 | $387.07K 20-F · filed 2021-10-29 |